Category: Novartis
-
Supreme Court of India sidesteps patent-related questions in SEP as well as pharma contexts by declaring cases moot
The Supreme Court of India shows little appetite for patent and patent-related cases, looking for ways to declare cases moot rather than addressing legal issues.